Press "Enter" to skip to content

Suven Life gets product patents from Brazil, Eurasia

These patents are valid through 2023 and 2034, respectively, the company said in a BSE filing.

Original source: https://health.economictimes.indiatimes.com/news/pharma/suven-life-gets-product-patents-from-brazil-eurasia/67270989?utm_source=RSS&utm_medium=ETRSS

Also Read:   Novartis sickle-cell drug gets U.S. FDA approval